Neuromuscular Characteristics of Individuals With Down Syndrome (DS)

December 15, 2023 updated by: State University of New York - Upstate Medical University

Neuromuscular Characteristics of Individuals With Down Syndrome

Evaluation of muscle strength and central activation of muscle in individuals with Down Syndrome

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Syracuse, New York, United States, 13210
        • IHP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Individuals with Down Snydrome and control subjects without DS

Description

Inclusion Criteria:

  • 18-45 years old
  • good health with no contraindications to exercise
  • documented DS (not for control subjects)

Exclusion Criteria:

  • contraindications to exercise,
  • severe or profound MR
  • documented atherosclerotic heart disease
  • documented atlantoaxial instability
  • uncorrected congenital heart disease
  • implanted prosthetic device
  • implanted pacemaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
DS
Individual with Down Syndrome
Other: muscle strength
muscle strength

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Muscle strength Central activation ratio
Time Frame: One time
One time

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

State University of New York - Upstate Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

March 24, 2008

First Submitted That Met QC Criteria

March 25, 2008

First Posted (Estimated)

March 26, 2008

Study Record Updates

Last Update Posted (Estimated)

December 21, 2023

Last Update Submitted That Met QC Criteria

December 15, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 5495

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe